Biopol Chemicals Ipo
Biopol Chemicals IPO Review & Key Points
Review: Neutral
IPO Lead Managers aka Merchant Bankers
Smart Horizon Capital Advisors Pvt. Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 2 | 2,400 | ₹2,59,200 |
| Retail Maximum | 2 | 2,400 | ₹2,59,200 |
| S-HNI Minimum | 3 | 3,600 | ₹3,88,800 |
| S-HNI Maximum | 7 | 8,400 | ₹9,07,200 |
| B-HNI Minimum | 8 | 9,600 | ₹10,36,800 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 6,86,400 Shares | 23.71% |
| NII Shares Offered | 10,94,400 Shares | 37.81% |
| Retail Shares Offered | 9,62,400 Shares | 33.25% |
| IPO Open Date: | February 6, 2026 |
| IPO Close Date: | February 10, 2026 |
| Basis of Allotment: | February 11, 2026 |
| Refunds: | February 12, 2026 |
| Credit to Demat Account: | February 12, 2026 |
| IPO Listing Date: | February 13, 2026 |
| IPO Bidding Cut-off Time: | February 10, 2026 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 79,11,000 | 89.88% |
| Promoter Holding Post Issue | 1,08,05,400 | 65.81% |
| Purpose | Crores |
| Acquisition of industrial land | ₹12.26 |
| Repayment or prepayment, in full or in part, of borrowings availed by the Company from banks, financial institutions and non-banking financial companies | ₹11.10 |
| General Corporate Purpose | ₹- |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2024 | ₹17.43 | ₹15.72 | ₹2.96 | ₹17.56 |
| 2025 | ₹49.15 | ₹43.35 | ₹4.33 | ₹31.48 |
| Dec 2025 | ₹48.97 | ₹40.89 | ₹6.00 | ₹48.88 |
| KPI | Values |
| ROE: | 38.10% |
| ROCE: | 30.57% |
| EBITDA Margin: | 13.30% |
| PAT Margin: | 8.81% |
| Debt to equity ratio: | 0.57 |
| Earning Per Share (EPS): | ₹5.47 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 32.00% |
| Net Asset Value (NAV): | ₹17.10 |
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Rossari Biotech Limited | 24.63 | 20.93 | 15.62% | 194.56 | – Cr. |
| Fineotex Chemical Limited | 9.44 | 2.30 | 19.31% | 54.93 | – Cr. |
| Indian Emulsifiers Limited | 10.88 | 7.19 | 20.01% | 91.04 | – Cr. |
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
| IPO Open Date | February 6, 2026 |
| IPO Close Date | February 10, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹102 to ₹108 Per Share |
| Issue Size | Approx ₹31.26 Crores |
| Fresh Issue | Approx ₹31.26 Crores |
| Issue Type | Book build Issue |
| IPO Listing | NSE SME |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |